Last reviewed · How we verify

blood sampling before radiotherapy

Centre Paul Strauss · Phase 1 active Biologic ✓ Verified May 2026 Quality 25/100

blood sampling before radiotherapy is a Biologic drug developed by Centre Paul Strauss. It is currently in Phase 1 development.

Blood sampling is a procedure used in various clinical trials, including those for Acute Graft-versus-Host Disease, Allogeneic Stem Cell Transplant, and Acute Myeloid Leukemia. The blood samples are typically taken from patients undergoing treatments such as Allogeneic Hematopoietic Stem Cell Transplantation and Bone Marrow Transplantation.

Likelihood of approval
9.6% vs 9.6% industry baseline
If approved by FDA: likely 2033–2036
Steps remaining: Phase 2 → Phase 3 → NDA/BLA submission
Confidence: Medium
Why this estimate
  • Baseline phase 1 → approval rate +9.6pp
    Industry-wide phase 1 drugs reach approval ~9.6% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).
Predicted approval windows by jurisdiction (conditional on FDA approval)
Regulator Country Likely year Lag vs FDA
FDA US 2033–2036 —
EMA EU 2034–2037 +0.7 yr
MHRA GB 2034–2037 +0.7 yr
Health Canada CA 2034–2038 +0.9 yr
TGA AU 2034–2038 +1.2 yr
PMDA JP 2034–2038 +1.5 yr
NMPA CN 2035–2039 +2.3 yr
MFDS KR 2034–2038 +1.4 yr
CDSCO IN 2034–2039 +1.8 yr
ANVISA BR 2035–2039 +2.3 yr

Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).

Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.

At a glance

Generic nameblood sampling before radiotherapy
SponsorCentre Paul Strauss
ModalityBiologic
PhasePhase 1

Approved indications

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about blood sampling before radiotherapy

What is blood sampling before radiotherapy?

blood sampling before radiotherapy is a Biologic drug developed by Centre Paul Strauss.

Who makes blood sampling before radiotherapy?

blood sampling before radiotherapy is developed by Centre Paul Strauss (see full Centre Paul Strauss pipeline at /company/centre-paul-strauss).

What development phase is blood sampling before radiotherapy in?

blood sampling before radiotherapy is in Phase 1.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing